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1. Introduction 
Two of us have reported [ 1,2] the synthesis of the 
metabolite of vitamin Ds 25,26-dihydroxycholecal- 
ciferol(25,26(OH)aDs), which led to a mixture of 
the C-25 epimers and more recently [3] the resolu- 
tion of these latter by HPLC. The absolute configura- 
tion of the epimers could be established [4] by X-ray 
diffraction analysis. One of these epimers must be 
identical with the natural metabolite 25,26(OH)aDa 
isolated from porcine plasma [5] and more recently 
generated biologically [6]. Its configuration at C-25 
remained unknown. 
The present report describes the identification of 
the natural 25,26(OH)sDa with 25R ,26(OH)aDs. 
It was achieved by HPL co-C of their 3,25,26-Tris- 
TMS derivatives by a procedure similar to that used in 
[7] for the identification of the natural 24,25(OH)aDs 
2. Experimental 
2.1. Instruments 
HPLC was performed with a Waters Associates 
chromatograph,equipped with a 6000A pump, a 
U6K injector, a 254 nm ultraviolet detector and a 
Abbreviations: 25-OH-D,, 25-hydroxycholecalcifeferol; 
1,25(OH),D,, 1,25dihydroxycholecalciferol; 25,26(OH),D,, 
25,26-dihydroxycholecalciferol; 24,25(OH),D,, 24,25- 
dihydroxycholecalciferol; TMS, trimethylsilyl; HPL(co-)C, 
high pressure liquid (co-)chromatography; TLC, thin layer 
chromatography 
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30 cm X 4 mm i.d. column of Microporasil. The 
mobil phase was n-hexane containing 2% (v/v) 
dichloromethane at a flow rate of 1 ml/min and a 
pressure of 42 kg/cm2. 
The radioactivity was determined using a counting 
solution (Liquid Scintillator Unisolve 1, Koch-Light 
Lab.) and a liquid scintillation counter (Intertechnique 
Model SL 40). 
2.2. Preparation and purification of biological 
radioactive 25,26(OH),D, 
Vitamin D-deficient chicks were given an injection 
of 6.5 nmol vitamin Da in 0.05 ml ethanol sub- 
cutaneously 48 h before they were killed by decapita- 
tion. Kidneys were removed, placed in ice-cold sucrose 
(0.25 M) and homogenized to yield a 20% homogenate 
(w/v) in 0.19 M sucrose containing 15 mM Tris- 
acetate (pH 7.4) and 1.9 mM magnesium acetate. An 
aliquot of the homogenate containing 200 mg 
kidney tissue was incubated in a 25 ml Erlenmeyer 
flask in a final 1.5 ml. The reaction mixture ultimately 
contained 0.19 M sucrose, 15 mM Tris-acetate 
(pH 7.4) 1.9 mM magnesium acetate and 25 mM 
succinate. The contents of the flask were flushed for 
30 s with 100% oxygen and stoppered. The substrate 
(2.6 nmol 25-OH-[23,24-3H]D3 dissolved in 0.02 ml 
95% ethanol) was added to each vessel. The reaction 
mixtures were incubated at 37°C for 10 min. The 
reaction was stopped by the addition of 10 ml 
dichloromethane. Extraction was carried out by the 
dichloromethane extraction procedure in [8]. The 
dichloromethane extracts were applied directly to a 
Sephadex LH-20 column (2 X 34 cm) eluted with 
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hexane:chloroform:methanol(9:1: 1) to resolve 
25,26(OH)?Ds from 1 ,25(OH)zDs as in [9) . The 
25,26(OH)zDs was applied in total to a HPLC 
system equipped with a DuPont Zorbax-SIL column 
(4.6 mm X 25 cm) developed with a solvent system of 
9% isopropanol in hexane at 7000 p.s.i. The purified 
25,26(OH)*Ds was then used for co-chromatography 
with the synthetic material as described in sections 
2.3 and 2.4. 
2.3. Preparation of 3,2.5,26-Tris- TMS derivatives of 
25,26(OH)zDs 
Mixture of synthetic [3] 25R,26- and 
25S,26(OH)zD3 (1.5 pg each) were treated with 
trimethylsilylimidazol(4 ~1) in n-hexane (100 ~1) at 
50°C for 30 min and left at room temperature for 
12 h. The structure of 3,25,26-Tris-TMS derivatives 
was confirmed by TLC [2]. The solvent was evap- 
orated under nitrogen, the residue dissolved in 
n-hexane containing 2% (v/v) dichloromethane, 
filtered and injected into the HPLC system. 
2.4. Co-chromatography with radioactive 
25,26(OH)zDa 
In experiments with biologically generated 
25,26(0H)2-[23,24-3H]D3, the radioactive material 
was added to the mixture of epimeric 25R,26- and 
25S,26(OH)*D3 and treated as above. Fractions were 
collected at 30 s intervals and the radioactivity deter- 
mined in each fraction. 
3. Results 
Figure 1 illustrates the separation of the Tris-TMS 
derivatives of 25R,26- and 25S,26(OH)2D3 achieved 
by HPCL on high surface area silica. The retention 
time for the 25,~ epimer was 62 min while that for 
the 25R one was 65 min. 
In experiments with biologically generated 
25,26(OH)*- [23 ,24-3H] D3 the radioactivity migrates 
with the derivative of 25R ,26(OH)2D3. Recovery for 
the radioactivity was 70%. 
4. Discussion 
Our results demonstrate clearly that the natural 
25,26(OH)?D3 has a 25R configuration. This has 
been established first by preparing [3] synthetically 
the two C-25 epimers of 25,26(OH)?D3 and assigning 
[4] their respective configurations by X-ray studies. 
Then a method for separating the epimers as Tri-TMS 
ethers by HPLC was elaborated and it was found that 
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Fig.1. Separation of the Tri..TMS ethers of 25R,26- and 25S,26(OH),D, and co-chromatography of the Tris-TMS ether of 
radioactive biologically generated 25,26(OH),D, with the 25R,26(OH),D, derivative. The clear bars represent radioactivity in 
each fraction. 
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the derivative of 25,26(OH)2D3 of biological origin 
migrated with the 25R,26(OH)*D3 derivative. 
It is of interest to note that another polar metab- 
olite of vitamin DJ, 24,25(OH)2D3 has been recently 
[7] identified with 24R,25(OH)2Dg. But while the 
natural 24R,25(OH)2D3 was superior to the syn- 
thetic 24s epimer in elevating serum phosphorus and 
in the calcification of bone in rachitic rats [7] , the 
natural 25R,26(OH)2D3 is surprisingly less effective 
[3] than 25S,26(OH)2D3 in this biological system. 
The natural 25 ,26(OH)*D3 isolated from porcine 
plasma has been found [5] inactive in the cure of 
rickets in rats. 
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